SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-007551
Filing Date
2022-03-23
Accepted
2022-03-23 16:35:51
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1362027
2 ex23-1.htm EX-23.1 4484
3 ex31-1.htm EX-31.1 11592
4 ex31-2.htm EX-31.2 11147
5 ex31-3.htm EX-31.3 12177
6 ex32-1.htm EX-32.1 12718
  Complete submission text file 0001493152-22-007551.txt   5604483

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cocp-20211231.xsd EX-101.SCH 41304
8 XBRL CALCULATION FILE cocp-20211231_cal.xml EX-101.CAL 61074
9 XBRL DEFINITION FILE cocp-20211231_def.xml EX-101.DEF 161763
10 XBRL LABEL FILE cocp-20211231_lab.xml EX-101.LAB 359991
11 XBRL PRESENTATION FILE cocp-20211231_pre.xml EX-101.PRE 286019
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 731235
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 22763611
SIC: 2834 Pharmaceutical Preparations